InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Emergent BioSolutions Inc.

EBS Clue Score47
United States Fiscal year ends December CIK 0001367644 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Donald W DeGolyer
7 Oct 2026
Director
Sold on a plan
17,800
$7.09
$126.20K
Paul Anthony Williams
1 Oct 2026
SVP, Products Business
Sold on a plan
3,000
$6.53
$19.59K
Paul Anthony Williams
1 Jul 2026
SVP, Products Business
Sold on a plan
3,000
$8.40
$25.20K
Kathryn C Zoon
1 May 2026
Director
Sold on a plan
1,057
$8.97
$9.48K
Kathryn C Zoon
1 May 2026
Director
Sold on a plan
16,145
$8.36
$134.97K
Donald W DeGolyer
1 May 2026
Director
Sold on a plan
954
$8.96
$8.55K
Donald W DeGolyer
1 May 2026
Director
Sold on a plan
14,527
$8.36
$121.45K
Sujata Tyagi Dayal
1 May 2026
Director
Sold on a plan
980
$8.94
$8.76K
Sujata Tyagi Dayal
1 May 2026
Director
Sold on a plan
12,781
$8.36
$106.85K
Keith Katkin
30 Apr 2026
Director
Sold on a plan
15,481
$8.28
$128.18K
Paul Anthony Williams
1 Apr 2026
SVP, Products Business
Sold on a plan
4,000
$8.44
$33.76K
Kathryn C Zoon
15 Aug 2025
Director
Sold on a plan
7,086
$8.87
$62.85K
Keith Katkin
23 May 2025
Director
Sold on a plan
7,844
$6.30
$49.42K
Kathryn C Zoon
2 Jun 2023
Director
Sold on a plan
1,830
$8.35
$15.28K
Kathryn C Zoon
25 May 2023
Director
Sold on a plan
1,700
$8.38
$14.25K
Show all 209 transactions →

What was left out

Form 4 filings counted 420
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 79
Sales at will 108
Transactions with no price 0
Shares from compensation/vesting 9,734,290
Sales filed before the plan box existed 97
History held since 21 Nov 2006